RIGEL PHARMACEUTICALS INC (RIGL)

US7665597024 - Common Stock

17.38  +0.06 (+0.35%)

After market: 17.38 0 (0%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
157.47M116.88M120.20M149.20M108.60M
Cost Of Goods
16.65M7.11M1.70M1.10M900.00K
Gross Profit
140.83M109.77M118.50M148.20M107.70M
Operating Expenses
131.32M130.26M172.80M157.10M136.70M
Research and Development
20.93M24.52M60.30M65.20M60.10M
Selling, General, and Administrative Expenses
110.39M105.74M112.50M91.90M76.60M
Operating Income
9.50M-20.49M-54.30M-9.00M-29.00M
Interest Income/Expense
-5.62M-4.60M-3.00M-4.80M-800.00K
Non Recurring Items
N/AN/A-1.30M-3.50MN/A
Income Before Taxes
3.88M-25.09M-58.60M-17.30M-29.70M
Income Tax
N/AN/A0.00600.00KN/A
Net Income
3.88M-25.09M-58.60M-17.90M-29.70M
EBITDA
11.41M-19.25M-53.30M-7.84M-28.29M
 
Per Share Data
EPS Diluted Total Ops
0.22-1.44-0.34-0.11-0.18
Non GAAP EPS
0.14-1.50-3.40-1.10-1.60
 
Statistics
Gross Profit Margin
89.43%93.92%98.59%99.33%99.17%
Profit Margin
2.46%-21.47%-48.75%-12.00%-27.35%
Operating Profit Margin
6.03%-17.53%-45.17%-6.03%-26.70%

All data in USD

Charts